Amino acid replacement: ?1724term.
C9537056T
Q1723term | brp-PD; Q1723term | brp-PE; Q1769term | brp-PG; Q1723term | brp-PH; Q1380term | brp-PI; Q2221term | brp-PJ; Q1690term | brp-PK; Q1764term | brp-PL; Q1481term | brp-PM; Q2226term | brp-PN; Q1660term | brp-PO; Q1776term | brp-PP; Q1778term | brp-PQ; Q1765term | brp-PR
?1724term
Nonsense mutation at at amino acid position 1724 (out of 1740). Site of nucleotide substitution in mutant inferred by FlyBase based on reported amino acid change.
synaptic vesicle | larval stage (with brp69)
T-bar | larval stage (with brp69)
brpnude/brp69 larvae have significantly reduced locomotion, compared to controls; they also have significantly reduced numbers of synaptic vesicles around motor neuron T-bars and significantly reduced NMJ presynaptic active zone area, compared to controls, with no effect on the number of presynaptic active zones; there is no effect on the rate of miniature excitatory postsynaptic currents (minis) in muscle 6 at the NMJ or on excitatory postsynaptic current (eEPSC) amplitude or decay time constant, compared to controls, but paired-pulse depression of eEPSCs is significantly increased, compared to controls.
brpnude/+ larvae have significantly increased locomotion, compared to controls.
The area of the active zone cytomatrix at mutant active zones is reduced compared to controls (assayed using direct stochastic optical reconstruction microscopy).
Both paired pulse-stimulation and high-frequency trains of activity produced pronounced short-term depression of evoked excitatory postsynaptic currents in mutant larval neuromuscular junctions. The fast phase of recovery after high-frequency stimulation is slowed in the mutant compared to controls, while the slow recovery phase is normal.
brpnude mutants exhibit significantly reduced survival rates and motor abilities.
brpnude mutant neuromuscular junctions exhibit a normal number of active zones and normal cytomatrix distribution, with wild-type levels of dense bodies. Furthermore, the diameter of the synaptic vesicles as well as the total number of synaptic vesicles per bouton section are unchanged in brpnude mutants.
brpnude mutant synapses display normal Ca[2+] channel distribution.
EPSCs evoked at 0.2Hz at brpnude mutant synapses do not differ in terms of their peak amplitude, rise time, or decay time constant from those of controls.
Depression decay during paired-pulse stimulation is stronger in brpnude mutants, as quantified by a reduction in the steady-state EPSC amplitude at the end of the train to 35% compared to 52% in controls. Consistent with the altered paired-pulse ratio, the amplitude of the second EPSC in the train is already significantly reduced to 80% at brpnude synapses.
brpnude mutant synapses display enhanced depression during sustained high frequency transmission. Consistently, the first component of recovery is slower, whilst the second component is unaltered.
brp69/brpnude has abnormal locomotor behavior | larval stage phenotype, enhanceable by cpxSH1/cpx1257
brp69/brpnude has abnormal neurophysiology | larval stage phenotype, enhanceable by Scer\GAL4RapGAP1-OK6/cpxUAS.RU.EGFP
brp69/brpnude has abnormal neuroanatomy | larval stage phenotype, non-enhanceable by cpxSH1/cpx1257
brp69/brpnude has abnormal neuroanatomy | larval stage phenotype, non-suppressible by cpxSH1/cpx1257
brp69/brpnude is a non-enhancer of abnormal locomotor behavior | larval stage phenotype of cpxSH1/cpx1257
brp69/brpnude is a suppressor | partially of abnormal neuroanatomy | larval stage phenotype of cpxSH1/cpx1257
brp69/brpnude is a non-suppressor of abnormal locomotor behavior | larval stage phenotype of cpxSH1/cpx1257
brpnude, cpx[+]/cpxSH1 has abnormal locomotor behavior | larval stage phenotype
brp69/brpnude, cpxSH1/cpx1257 has abnormal neurophysiology | larval stage phenotype
brp69/brpnude has embryonic/larval neuromuscular junction phenotype, enhanceable by Scer\GAL4RapGAP1-OK6/cpxUAS.RU.EGFP
brp69/brpnude has muscle cell of A1-7 ventral longitudinal muscle 3 phenotype, enhanceable by Scer\GAL4RapGAP1-OK6/cpxUAS.RU.EGFP
brp69/brpnude has synaptic vesicle | larval stage phenotype, non-enhanceable by cpxSH1/cpx1257
brp69/brpnude has presynaptic active zone | larval stage phenotype, non-enhanceable by cpxSH1/cpx1257
brp69/brpnude has embryonic/larval motor neuron phenotype, non-enhanceable by cpxSH1/cpx1257
brp69/brpnude has synaptic vesicle | larval stage phenotype, non-suppressible by cpxSH1/cpx1257
brp69/brpnude has presynaptic active zone | larval stage phenotype, non-suppressible by cpxSH1/cpx1257
brp69/brpnude has embryonic/larval motor neuron phenotype, non-suppressible by cpxSH1/cpx1257
brp69/brpnude is a non-enhancer of synaptic vesicle | larval stage phenotype of cpxSH1/cpx1257
brp69/brpnude is a suppressor of presynaptic active zone | larval stage phenotype of cpxSH1/cpx1257
brp69/brpnude is a non-suppressor of synaptic vesicle | larval stage phenotype of cpxSH1/cpx1257
brpnude/+; cpxSH1/+ double heterozygous larvae have significantly reduced locomotion, compared to controls, unlike either heterozygote alone.
brpnude/brp69; cpx1257/cpxSH1 double mutants have suppression of the increased eEPSC amplitude and mini frequency of cpx1257/cpxSH1 mutant larval muscle 6 and enhancement of the paired-pulse depression seen in both brpnude/brp69 mutants and cpx1257/cpxSH1 mutants.